» Articles » PMID: 28859632

Case Report of Anti-N-methyl-D-aspartate Receptor Encephalitis in a Middle-aged Woman with a Long History of Major Depressive Disorder

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2017 Sep 2
PMID 28859632
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disease involving antibodies against the NR1 subunits of NMDARs. The disease shows variable clinical presentation, and involves new-onset acute psychotic symptoms, making it difficult to differentiate from major depressive disorder with psychotic symptoms. Potential associations between this autoimmune disorder and onset or progression of major depressive disorder remains unclear.

Case Presentation: We present a rare case of a patient who had both major depressive disorder and anti-NMDAR encephalitis and in whom the encephalitis initially went undetected. The patient had been suffering from depressive disorder for more than 6 years without any treatment, when she was hospitalized for new-onset psychotic symptoms. She was initially diagnosed only with major depressive disorder with psychotic symptoms, but antipsychotics did not alleviate symptoms and the patient's psychiatric course began to fluctuate rapidly. Anti-NR1 IgG autoantibodies were detected in cerebrospinal fluid, and the combination of immunotherapy and antipsychotics proved more effective than antipsychotics alone. The patient was then also diagnosed with anti-NMDAR encephalitis.

Conclusions: Our case suggests that clinicians should consider anti-NMDAR encephalitis when a patient with depressive disorder shows sudden fluctuations in psychiatric symptoms. It also highlights the need for research into possible relationships between anti-NMDAR encephalitis and major depressive disorder.

Citing Articles

Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature.

Wright M, Guasp M, Lachner C, Day G, Gombolay G, Titulaer M J Neuroimmunol. 2024; 392:578369.

PMID: 38823118 PMC: 11539951. DOI: 10.1016/j.jneuroim.2024.578369.


Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis in patients with a long-term history of mental disorders.

Wang H, Yang X, Han J, Liu H, Yan Z, Liang Z Eur J Med Res. 2022; 27(1):38.

PMID: 35272706 PMC: 8908639. DOI: 10.1186/s40001-022-00664-5.


Case Report: Severe Adolescent Major Depressive Syndrome Turns Out to Be an Unusual Case of Anti-NMDA Receptor Encephalitis.

Moldavski A, Wenz H, Lange B, Rohleder C, Leweke F Front Psychiatry. 2021; 12:679996.

PMID: 34113272 PMC: 8185133. DOI: 10.3389/fpsyt.2021.679996.

References
1.
Maneta E, Garcia G . Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications. Psychosomatics. 2013; 55(1):37-44. DOI: 10.1016/j.psym.2013.06.002. View

2.
Irani S, Bera K, Waters P, Zuliani L, Maxwell S, Zandi M . N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010; 133(Pt 6):1655-67. PMC: 2877907. DOI: 10.1093/brain/awq113. View

3.
Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

4.
Wandinger K, Saschenbrecker S, Stoecker W, Dalmau J . Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2010; 231(1-2):86-91. DOI: 10.1016/j.jneuroim.2010.09.012. View

5.
Kayser M, Dalmau J . Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2014; 176(1):36-40. PMC: 4409922. DOI: 10.1016/j.schres.2014.10.007. View